RxNews Recap for 05-06-11 Print E-mail
By BioMedReports.com Staff   
Friday, 06 May 2011 20:11
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 6, 2010.

American Oriental Bioengineering, Inc. (NYSE:AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced that it plans to release first quarter 2011 financial results on Monday, May 9, 2011, after the market closes.

China Biologic Products, Inc. (Nasdaq:CBPO) ("China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that it will host its earnings conference call covering its first quarter 2011 results on May 10, 2011 at 7:30 a.m. EDT (New York), which is also 7:30 p.m. in China on the same day.

Cord Blood America, Inc. (OTCBB: CBAI, CBAID)
announced today that the effective date for the reverse split, approved by 80 percent of its shareholders voting in a recent proxy vote,  is the opening of the market on Monday, May 9, 2011.

Cytori Therapeutics (NASDAQ: CYTX) has appointed Clyde W. Shores as Executive Vice President of Marketing & Sales where he will lead the Company's strategic marketing initiatives for all product lines around the world.

CryoLife, Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, today announced the final results of its tender offer, including proration results, through its wholly owned subsidiary CL Falcon, Inc., for 49.9 percent of the outstanding shares of Cardiogenesis Corporation ("Cardiogenesis") (OTCQB: CGCP).  

Digirad Corporation (NASDAQ: DRAD) today reported first quarter revenue of $14.2 million and an ending cash and available-for-sale securities balance of $30.6 million at March 31, 2011.

Elysium Internet, Inc., dba TheDirectory.com (PINKSHEETS: EYSM), an emerging leader in the local business search and advertising market, today announced that it has entered into an exclusive partnership with local pay-per call provider Yext.com.

GeckoSystems Intl. Corp, (PINKSHEETS: GOSY) a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™,"  (http://www.geckosystems.com/) -- announced today that they expect receipt in late May of the first wheelchairs from Imasen Engineering Corporation, Japan's oldest wheelchair manufacturer.

Halozyme Therapeutics, Inc. (Nasdaq:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today reported financial results for the first quarter 2011.

InspireMD, Inc. (OTCBB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced that Mr. Ofir Paz, InspireMD's co-founder and chief executive officer, and Mr. Craig Shore, chief financial officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, May 12, 2011 at The Pfister Hotel, 424 East Wisconsin Ave., Milwaukee, Wis.

Oncothyreon Inc. (NASDAQ:ONTY) today reported financial results for the first quarter ending March 31, 2011.

ProPhase Labs (NASDAQ: PRPH) announced today that financial results for the first quarter, ended March 31, 2011, will be released before the market opens on Friday, May 13th.

Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that its elure™ Advanced Skin Lightening Technology will be featured at The Aesthetic Meeting 2011, which is being held from May 6-11, 2011 at the Boston Convention & Exhibition Center in Boston, MA.

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus